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Abstract
Background: Histologic samples all funnel through the H&E microtomy staining area. Here manual processes
intersect with semi-automated processes creating a bottleneck. We compare alternate work processes in anatomic
pathology primarily in the H&E staining work cell.
Methods: We established a baseline measure of H&E process impact on personnel, information management and
sample flow from historical workload and production data and direct observation. We compared this to
performance after implementing initial Lean process modifications, including workstation reorganization,
equipment relocation and workflow levelling, and the Ventana Symphony stainer to assess the impact on
productivity in the H&E staining work cell.
Results: Average time from gross station to assembled case decreased by 2.9 hours (12%). Total process
turnaround time (TAT) exclusive of processor schedule changes decreased 48 minutes/case (4%). Mean quarterly
productivity increased 8.5% with the new methods. Process redesign reduced the number of manual steps from
219 to 182, a 17% reduction. Specimen travel distance was reduced from 773 ft/case to 395 ft/case (49%) overall,
and from 92 to 53 ft/case in the H&E cell (42% improvement).
Conclusions: Implementation of Lean methods in the H&E work cell of histology can result in improved
productivity, improved through-put and case availability parameters including TAT.
Background
The core process of every anatomic pathology laboratory
has been the hematoxylin and eosin (H&E) stain for well
over 100 years. Sequential processing steps involved in
the diagnostic preparation of tissue–gross dissection,
selection of tissue blocks, processing, imbedding in par-
affin, cutting and mounting on glass slides, all funnel
through the final stages of staining, and cover-slipping
in preparation for review and diagnosis by a pathologist.
Efforts at automating or otherwise improving portions
of these processes over the past century have yielded
some significant gains, but have also at times introduced
potential for variation, defects, and delays. In not every
case have these been adequately studied before and after
changes have been introduced. A combination of
economic pressures to increase productivity in order to
maintain profitability, the need to hasten the time to
diagnosis while preserving ample time for study and
evaluation by pathologists and trainees, and the desire
to reduce sources of medical error have entailed upon
the histology laboratory the classic “rock and hard
place” logjam that cannot be solved by reliance upon
the status quo methods of the past. Industrial productiv-
ity and quality systems methods such as Lean and Six
Sigma have been introduced into healthcare and labora-
tory operations over the past several years to success-
fully confront this dilemma [1-4].
One of the problems in comparing practices between
top-performing labs, even among closely defined areas
of a lab such as histology, is that the metrics of mea-
surement are not sufficiently standardized to compen-
sate for all the variables impacting productivity and are
subject to considerable variation according to case mix
and other local circumstances. However, in undertaking
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performances can be utilized effectively as an evaluation
measure [5]. Whether such results can be matched else-
where may depend on a variety of factors including
those we have been able to identify, and others we have
not.
Lean methodology, adopted from industrial produc-
tion experience, has recently been advocated as a means
to improve laboratory financial performance while also
generating progress in patient safety. In reducing the
several types of waste inherent in most systems, the
reduced number of process steps and better-designed
“goof-proof” processes reduce variability and potential
for errors that may result in harm to patients. Several
publications documenting application of these tools to
laboratory processes, including histology processes, have
shown significant results [6,7]. While often quite
straight-forward and low-tech, Lean concepts are also
being embraced by vendors offering histology equipment
and solutions, which create new potential synergies in
performance.
In this paper, we present data from our experience in
combining low-tech Lean process improvements, work-
space redesign, and a Lean-engineered automated stain-
ing system, to the H&E workflow cell.
Methods
The histology laboratory at OU Medical Center operates
24 hours a day, six days a week, supporting the histology
needs for the OU Medical Center, The Children’sH o s -
pital at OU Medical Center, the OU Physicians, Okla-
homa State Health Department, OU Oral Pathology and
some on-campus research operations. The need to
improve TAT for the benefit of patient care and fiscal
performance, together with our efforts to maintain or
improve the time trainees have to review case material
prior to sign-out, impelled us to look for tools like Lean
to help us meet the demands of our practice situation.
Also, volume growth (aka market share) is an important
goal of the medical center, which has worked to
improve through-put in the operating room suites, and
has plans for additional out-patient procedure areas.
While accession volume over the recent past has seen
only limited growth, on-campus expansion is occurring
as a new cancer center and an ambulatory surgery cen-
ter are nearing completion and additional physician
space created. It is expected that the slope of the growth
curve will shift upwards. Space constraints, in addition
to the ubiquitous budgetary pressures, limit the histol-
ogy lab’s ability to add personnel beyond the seven full
time equivalent (FTE) employees currently devoted to
routine H&E production.
We used non-concurrent production data to assess
productivity under initial and redesigned systems of
workflow. Raw block and slide count data as tabulated
monthly were combined with worked hours and nor-
malized to produce a productivity ratio to track overall
process production (Number of blocks + number of
slides/[total hours worked/173 hours/FTE]). Only
employees engaged in the core histology processes (i.e.
excluding special staining procedures) were included.
Other studies have also used this generic method of
workload and productivity measurement for both inter-
nal and external comparison [5]. We employ this
method for before and after measurements for compari-
son with other published studies, recognizing that our
case and specimen mix is different from many other
laboratories and that gross block and slide count is an
imperfect measure of workload. Statistical comparison
of before and after productivity was performed using the
student’s two tail t-test, as our measurements of this
parameter show a normal (Gaussian) distribution of
values over time (mean, median and mode not signifi-
cantly different.) The employees engaged in this section
o ft h el a b o r a t o r yd i dn o tc h a n g eo v e rt h es t u d yp e r i o d
and the differences in volumes were negligible.
Histology section processes, through-put and capacity
at baseline were directly measured by observation of
sample cases on a typical day by an experienced, Lean-
trained observer not employed within the laboratory, as
part of an overall value stream analysis. Randomly
selected cases were time stamped at each stage of pro-
gress through histology processing. Repeat time stamp
random case study following process modifications were
used for comparison. Within process total turnaround
times were compared for the time stamped sample cases
before and after process changes. Waiting times between
steps were included in these measurements. Percent
improvements were calculated. Cycle time (total time
required to produce a single unit) and takt time (the
ratio of the time available to do the work to the number
of units produced or demanded in that time) measures
were made per standard methods. We used daily case
and slide log sheets to determine the time of delivery of
the last case each day, as well as the number of cases
available at earlier points in the process. The number of
days per month when new cases were distributed to
pathologists after 10 am was used as a measure of the
robustness of the process changes to handle variations
in volume and workplace or staffing variability.
Sequential step mapping with decision points and
alternative pathways displayed were used to visualize
opportunities for simplification or improvement. The
process improvement team collaborated with vendors to
identify how instrumentation changes could impact the
overall flow of work. In the H&E workcell, we selected
the Ventana Symphony system. This instrument inte-
grates the baking, staining and coverslipping functions
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individually adjustable process that allows continuous
sequential flow of trays of up to 20 slides.
Engaging histology laboratory workers in the change
process is important. Measuring ourselves on the four
axes of “change readiness” supported our sense that
active management of the changes would be imperative
to our success [8] (Figure 1). Sustained change cannot
be accomplished without the involvement and participa-
tion of workers at all levels of an operation. To do this
in our laboratory, we sought first the support and invol-
vement of senior leadership, both on the physician and
hospital sides of our operation. We provided data on
the patient safety risks present in our current methods,
education in current business and fiscal climate, and
reassurances that our goal in improving efficiency was
not to eliminate positions. We charged small teams
across various boundaries with study and implementa-
tion of portions of the transformation. We encouraged
employee input on process changes and improvements.
Sometimes this meant that we encountered push-back
from those who felt changes were not needed or that
proposed changes would not be demonstrably better.
We provided quantitative data and graphics of our cur-
rent state, and where the projected changes could take
us to attempt to allay active resistance and engage
support.
We conducted initial and interim cost analysis of the
project to determine the economic impact on opera-
tions. We used real salary and benefits data for the
employees in the H&E work cell. Actual incurred costs
for instrumentation changes were included, as well as
overall costs for space renovation, although some of
these were part of the larger workflow redesign. Cost
savings or increases associated with the project were
derived from actual reagent and supply costs, observed
production changes and the inferred deferral of addi-
tional staff to accommodate projected growth, as well as
the deferred need for space expansion or additional
instrumentation to meet volume demands. In addition,
cost avoidance associated with a reduction in liability
was calculated from the experience of other laboratories
with underwriter-reduction in liability rates following
adoption of similar processes (Judy Frost, MPL, personal
communication.)
Results
Our baseline process studies, based on an average
demand of 500 slides per day (62 cases,) revealed a takt
time of 2.61 minutes. However, measurement of the
capability of each process step demonstrated an inability
of the status quo methods to meet this demand in the
areas of gross dissection, microtomy and H&E staining.
(Figure 2) As is evident from the graph, the biggest bot-
tleneck was in the H&E staining step. While reducing
non-value adding steps could bring the other processes
below the takt time threshold, this alone would not
work in the H&E production workcell. This workcell
used a semi-automated batch stainer, an automated cov-
erslipping device, in addition to traditional embedding
stations with integrated paraffin dispenser and cold
plate, and manual microtomes. Different case types were
embedded in batches as they came from the tissue pro-
cessor, then moved in batches to the microtomy stations
where batches of slides were prepared, and the sections
made. Baking and staining then ensued, also in batches.
Case assembly happened as groups of finished slides
came off the coverslipping device and were matched
4 of 4 dimensions support a high to medium need for change management
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1 10
High Recognition Low Recognition
How widely acknowledged are the risks of the status quo?
(Quality, Patient Safety, Productivity)
1 10
High Recognition Low Recognition
What is the level of severity if the change fails?
(Strategic Alignment, Lost Opportunity, Loss of Credibility)
1 10
Not a big deal Very Severe
What is the level of severity if the change fails?
(Strategic Alignment, Lost Opportunity, Loss of Credibility)
1 10
Not a big deal Very Severe
? l a r e n e g n i d n a y l l a r u t l u c -n o i t a z i n a g r o e h t r o f e g n a h c s i h t s i g i b w o H
(Day to day work activities, Decision making, Logistically)?
1 10
Minor changes Major Changes
? l a r e n e g n i d n a y l l a r u t l u c -n o i t a z i n a g r o e h t r o f e g n a h c s i h t s i g i b w o H
(Day to day work activities, Decision making, Logistically)?
1 10
Minor changes Major Changes
How much are the benefits of this change recognized by those inv olved in the change?
(Cost Reduction, Employee Satisfaction)
1 10
High Recognition Low Recognition
How much are the benefits of this change recognized by those inv olved in the change?
(Cost Reduction, Employee Satisfaction)
1 10
High Recognition Low Recognition
X
X
X
X
Figure 1 Self-Assessment of our status on four dimensions of “change readiness”.
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the pathologist.
Following an implementation of the floorplan and pro-
cess changes described here (Figures 3 and 4), and
installation of the Symphony integrated staining/cover-
slipping machines, including elimination of multiple
process steps that were considered non-value-adding,
the cycle time for this workcell was projected to be
reduced such that the overall takt time could be sus-
tained. Total process and floorplan redesign projects
substantial movement savings as detailed in Figure 5,
with a breakdown of potential savings by process step.
Raw measurements of productivity showed improve-
ment in productivity data immediately following imple-
mentation of the H&E workcell modification. These
results show statistical significance (Table 1 and Figure
6).
The distance-travelled graphics in the baseline state
and in the redesigned state are presented in Figure 5.
Specimen movement distances were decreased within
the H&E workcell from 92 to 53 feet, a reduction of
42%. These reconfigurations of workcell instrumentation
and organization represented a collaborative effort of
consultants, lab team members and leadership.
Time to first available slides decreased from a mini-
mum of 12 hours to four hours. The primary intent of
this was to provide added time for resident review of
slides prior to sign-out, and was accomplished by use of
a short sequence processor run for biopsy specimens
arriving in the laboratory in the morning and a second
large section run for tissues fixed overnight before cut-
ting the following morning. By introducing these modifi-
cations 17% of the total workflow was shifted from a
night-shift time to an afternoon time, and this contribu-
ted greatly to the overall change in average time from
gross station to finished slides of 2.9 hours. This change
however, also meant that the average time at which the
last case was presented for diagnosis also improved
from 9:59 to 8:55, an improvement of one hour and
four minutes. The number of days in which new slides/
cases were arriving on the pathologist’s desk for diagno-
sis after 10 am was reduced 50%.
The process evaluation identified several significant
wait times between steps, in addition to the bottlenecks
noted above in actual process capability, some of which
were eliminated or reduced by the changes implemented
to date. (Table 2) These were noted to be significant
barriers, and an opportunity for large gains in TAT,
even if we were only able to reduce them by half. This
portion of the project, focused on the last two of these
pauses, was successful in reducing the measured times
by 11%. Through altering the work flow and manner of
work, and adding additional processor runs, the waiting
times at gross dissection, case assembly and the micro-
tome were decreased. We encountered resistance to the
changed work methods calling for single piece flow
embedding and cutting steps, as evidenced by persis-
tence of a 2.5 hour wait observed between embedding
and microtomy. Future anticipated process accountabil-
ity changes are expected to overcome this. By using the
Symphony stainer to allow continuous case flow, gener-
ally assigning a single case to a single tray, we further
facilitated the process.
Process simplification and worker efficiency gains
from installation of the Symphony automated platform
appear significant. Both the Microtomy and H&E Stain-
ing workbenches were positively impacted as illustrated
in green (Figures 7 and 8). At the microtomy bench, a
total of seven manual and highly variable steps are
replaced by a simple single step leading to loading
Symphony (Figure 7). At the H&E Staining bench, thir-
teen steps are now automated. A total of 23 minutes of
0.5 m.
0.5 m.
2.3 m.
2.3 m.
0.208 m.
0.208 m.
5 m.
3.95 m.
2.5 m.
2.5 m.
1.2 m.
1.2 m.
1.53 m.
1.2 m.
0 m.
0 m.
3.72 m.
1.72 m.
10 m.
5 m.
1.67 m.
1.17 m.
1.8 m.
1.8 m.
1.0 Receiving
2.0 Accessioning
3.0 Cassette Marking
4.0 Grossing
5.0 Tissue Processing
6.0 Create Slides
7.0 Embedding
11.0 Review & Archival
8.0 Microtomy
9.0 H&E Staining
12.0 Recuts, SS, IHC
10.0 Case Assembly
Takt Time   2.61 m.
Total
NVA
Figure 2 Baseline process performance and threshold tatk time needed to match demand.
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Symphony (Figures 7 and 8). Coupled with eliminating a
queue area for slides that needed to go to the oven
prior to staining and to the coverslipper after staining, a
total of 30 minutes was saved as a result of converting
the H&E staining process from a semi-automated plat-
form to a fully automated platform. We did not capture
the amount of time spent draining and changing stains
in the baseline state, though we retrospectively estimate
this to be just over 1 hour per week with the slide
volume in our lab. With a direct waste line in the
Symphony however, no manual draining of waste is
needed. Additionally, over 32 feet (47%) of travel dis-
tance was removed from the Microtomy and H&E
Staining processes (Figure 4) - a total of 106 miles of
transport distance saved per year.
Figure 3 Baseline floorplans and process flow diagram.
Figure 4 Floorplan and process diagram following change.
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viously been a task for only the most meticulous of
technologists, as the chaos introduced between grossing,
processing trays, embedding stations, cutting areas, and
batch strainers often meant that a case was scattered
over several runs. Errors in assembly were common,
despite meticulous care. Delays due to the need to hunt
down an errant slide in another run were the norm.
Although not measured in the baseline state, the post-
change anecdotal impression is that an increased num-
ber come off the Symphony stainer complete and ready
to be presented to the pathologist. Cases with delayed
blocks (some case types, e.g. gynaecologic tumor debulk-
ing and staging procedures, often had smaller compo-
nent specimens along with large specimens that were
processed on separate processor runs from the major
resection) were however still easier to reassemble
because secondary portions arrive together at the end of
the staining process.
The results of our cost analysis show an actual
increase in our fully loaded operating cost per slide of
3.2% over baseline at our interim state, inclusive of
capital costs, service contracts, renovation and reagents
as well as labor. We project, based on historical
volume growth rates of 2.8%, to defer the need for
additional staff in the H&E workcell at least 11.6 years
due to the improved productivity observed from the
implemented changes to date. Another way of stating
that would be that the H&E work cell has the capacity
for over 32% more work before exceeding the takt
threshold for any of the process steps in this work cell.
We also project to defer the need for space expansion
and additional instrumentation, based similarly on his-
toric growth rates exclusive of known projects or
added contracts/clients, for at least 10 years. Inclusive
of these avoided costs (in 2009 dollars) and a reduc-
tion in liability costs, our cost/slide is reduced by 8.8%.
The payback period from operational savings for just
the improvements included in this portion of our pro-
ject then becomes 3.6 years.
Discussion
Lean production methods, originating in industrial set-
tings such as Ford, Toyota and elsewhere, have been
applied more broadly in the healthcare sector over the
past decade with encouraging results. Laboratories in
particular have been early adopters. Most of the reports
of such endeavours to date have emphasized the gains
to be had from innovative, but relatively low-tech
changes to established processes. However, an important
aspect of the Lean transformation of any industry is the
integration all along the value chain of suppliers, equip-
ment manufacturers and customers. (For example, a
parts manufacturer that only does batches of 100,000
isn’t going to mesh well with a customer who uses only
100 parts/week and will modify the product (and thus
the part design) after 12 months.) This report details
our experience working with one such vendor, Ventana
Medical Systems, in integrating a Lean-based advanced
stainer and coverslipping system, the Symphony, with
other more simple Lean process modifications. Increas-
ingly, equipment and reagent suppliers who recognize
this transformation in pathology and can “right-size”
products, offer “just-in-time” resupply and other Lean-
integration tools will gain advantage over more tradi-
tional vendors.
Step     Distance    Lean  Opportunity Final 
Accessioning 9  ft  3 ft     6 ft 
Cassette Marking  32 ft  16 ft   16 ft 
Grossing    38 ft  20 ft  18 ft 
Tissue Processing  88 ft  68 ft  20 ft 
Create Slides  22 ft  4 ft    18 ft 
Embedding   18 ft  5 ft   13 ft
Microtomy   42 ft  14 ft   28 ft
H&E Staining  32 ft  20 ft   12 ft
Case Assembly  126 ft  100 ft  26 ft 
Review/Archival   270 ft  120 ft  150 ft 
Recuts, SS, IHC  96 ft  25 ft    71 ft 
Total         773  ft 395 ft 378  ft
Figure 5 Summary of movement savings following
implementation.
Table 1 Comparison of monthly productivity following H&E workcell process change
Month Pre-change productivity (2007-8) Post-change productivity (2008-9)
November 2515 2593
December 2374 2598
January 2041 2259
February 2404 2575
March 2209 2534
Mean (SD) 2309 (185)* 2512 (143)*
* t < 0.0005 (two-tail test)
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butable to traditional, low-tech Lean process changes
such as processor scheduling, and work cell rearrange-
ments. But despite the perceived high price on linking
these with a Lean-engineered system like the Symphony
stainer, we have been able to demonstrate a reasonable
payback period for the capital expenditure and marginal
increase in direct operating costs. We believe this illus-
trates the feasibility and value in integrating technical
and process changes simultaneously and with deliberate
forethought.
Reports of potential impacts on productivity and turn-
around time have been published for some of the new
tissue processors [9], but no reports to date have
focused on the impact of single-piece flow H&E strai-
ners. The quality of productivity data in histology lags
behind that available for other laboratory sections, and
further dialogue and development of readily inter-
changeable methods are needed [10,11]. Our experience
shows that when combined with other Lean-oriented
redesign factors, an automated, single-piece flow stainer
and integrated coverslipping machine, even when
measured by rather gross traditional measures, can help
to increase overall productivity of histotechnologists and
improve times to case readiness. These changes have
created a more robust process that is less susceptible to
workload and work circumstances variations, as manifest
by substantial improvement in the average time of deliv-
ery of the last case of the day. We recognize however,
that there are still gains to be made in this arena. A
favourable impact on worker satisfaction, as well as
patient care through improved TAT, is an added benefit
to the conventional business case.
Individual histotechnologist productivity data was not
available in our baseline state, though future enhance-
ments we plan to incorporate will be able to capture
this data.
We have shown productivity improvement similar to
those demonstrated by Raab, et al [5] in their multi-year
implementation of Lean methods across the histology
lab at UPMC, assuming a proportionate allocation of
the improvements to each element of the workflow they
approached, and that presented in this study. Imple-
menting major changes in process among traditionally
Productivity
Before (2007-8)
After (2008-9)
0
1000
2000
3000
Before (2007-8)
After (2008-9)
Figure 6 Productivity gains from Lean implementation in H&E workcell.
Table 2 Inventory or wait times for specimens between process steps
Process step Wait pre-Lean Wait post-Lean Percent improvement
Accessioning to grossing 2.5 hours 2.5 hours 0.0%
Gross description to processor 3.5 3.0 14%
Embedding to microtomy 2.5 2.5 0.0%
Microtomy to H&E staining 1.0 0.75 25%
H&E Staining to Case Assembly 1.5 1.0 33%
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among those affected. It is important therefore to have
solid baseline data from which to project and demon-
strate improvement. This alone creates the case for
belief in the new process and thus enlists cooperation
rather than apathy, or active resistance. It is this princi-
ple which makes it imperative that measurement pre-
cede analysis or innovation in conventional Six Sigma
and Lean process change.
Conclusions
The improvements we have documented in our H&E
work cell herein described are the beginning of a longer
term and broader project to upgrade the performance of
our anatomic pathology laboratory. Some quick suc-
cesses have been realized, but the dramatic overall
returns we are seeking will most likely only come from
iterative application of the principles of Lean and Six
Sigma. We believe that the accrual of small changes
with marginal gains will become synergistic as additional
changes are implemented, and the culture of change and
process improvement is developed. The primary changes
we have presented here are limited to one work cell in
anatomic pathology, and we intend to continue to revise
our processes and integrate that with additional software
and technological tools to show continued gains. It is
clear that we can continue to reduce the waste in many
of our waiting times, and that this can be of benefit to
Figure 7 Pre- and Post-Symphony Impacted Process Steps (in green) at the Microtomy Workbench.
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tion of an automated staining system alone has pro-
duced some small but significant improvements in
productivity, and our projections indicate that these will
have a reasonable payback period due to significant cost
avoidances in additional labor, equipment, space and lia-
bility. We believe however, that when combined with
other integrated Lean process improvements and tech-
nologic tools, such a choice will be even more compel-
ling for those histology labs seeking to enhance the
quality, consistency and productivity of their output.
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